ETV5 anticorps (Ets Variant 5)

Details for Product anti-ETV5 Antibody No. ABIN969122, Fournisseur: Connectez-vous pour afficher
Antigène
  • ERM
  • etv5
  • fj87h10
  • id:ibd5133
  • wu:fj87h10
  • zgc:55647
  • 1110005E01Rik
  • 8430401F14Rik
  • ETS variant 5
  • ets variant 5
  • ets variant 5a
  • ETV5
  • Etv5
  • etv5a
Reactivité
Humain
104
16
15
7
6
6
6
6
4
3
2
2
1
1
Hôte
Souris
74
30
Clonalité (Clone)
Monoclonal ()
Conjugué
Cet anticorp ETV5 est non-conjugé
6
6
6
5
5
4
1
1
1
1
1
1
1
1
1
1
1
Application
ELISA, Western Blotting (WB)
84
55
18
13
9
4
4
3
3
2
Options
Fournisseur
Connectez-vous pour afficher
Supplier Product No.
Connectez-vous pour afficher
Immunogène Purified recombinant fragment of human ETV5 expressed in E. Coli.
Clone 3H3
Isotype IgG1
Purification Ascites
Autre désignation ETV5 (ETV5 Antibody Extrait)
Sujet ETS variant 5,transcription factor of the ETS family,divergent member of the winged helix-turn-helix superfamily,expressed in brain,placenta and other tissues involved in development. Tissue specificity: Ubiquitous. ERM is expressed in Sertoli cells and spermatogonial stem cells (SSCs). Studies on knockout mice have shown that it is required for SSC self-renewal but not differentiation, thus affected mice exhibit progressive germ cell depletion.
Poids moléculaire 58 kDa
ID gène 2119
HGNC 2119
Pathways Synaptic Membrane, Skeletal Muscle Fiber Development
Indications d'application ELISA: 1:10000, WB: 1:500 - 1:2000
Restrictions For Research Use only
Format Liquid
Buffer Ascitic fluid containing 0.03 % sodium azide.
Agent conservateur Sodium azide
Précaution d'utilisation This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock 4 °C,-20 °C
Stockage commentaire 4°C, -20°C for long term storage
Supplier Images
Western Blotting (WB) image for anti-Ets Variant 5 (ETV5) antibody (ABIN969122) Figure 1: Western blot analysis using ETV5 mouse mAb against Jurkat (1), NIH/3T3 (2) ...
Produit citée dans: Hotta, Nakamura, Nakamura, Matsuo, Nakata, Kamohara, Miyatake, Kotani, Komatsu, Itoh, Mineo, Wada, Masuzaki, Yoneda, Nakajima, Funahashi, Miyazaki, Tokunaga, Kawamoto, Ueno, Hamaguchi, Tanaka, Yamada et al.: "Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population. ..." dans: Journal of human genetics, Vol. 54, Issue 12, pp. 727-31, 2009 (PubMed).

Xie, Yin, Wang, Liu, Elashoff, Black, Koeffler: "Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 10, Issue 6, pp. 2072-81, 2004 (PubMed).

Chotteau-Lelièvre, Révillion, Lhotellier, Hornez, Desbiens, Cabaret, de Launoit, Peyrat: "Prognostic value of ERM gene expression in human primary breast cancers." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 10, Issue 21, pp. 7297-303, 2004 (PubMed).

Urzainqui, Serrador, Viedma, Yáñez-Mó, Rodríguez, Corbí, Alonso-Lebrero, Luque, Deckert, Vázquez, Sánchez-Madrid: "ITAM-based interaction of ERM proteins with Syk mediates signaling by the leukocyte adhesion receptor PSGL-1." dans: Immunity, Vol. 17, Issue 4, pp. 401-12, 2002 (PubMed).

Avez-vous cherché autre chose?